These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Use of non-physiological buffer systems in the analysis of methotrexate transport in L1210 cells. Henderson GB, Zevely EM. Biochem Int; 1983 Apr; 6(4):507-15. PubMed ID: 6679721 [Abstract] [Full Text] [Related]
9. Identification of cholate as a shared substrate for the unidirectional efflux systems for methotrexate in L1210 mouse cells. Henderson GB, Tsuji JM. Biochim Biophys Acta; 1990 Jan 23; 1051(1):60-70. PubMed ID: 2297542 [Abstract] [Full Text] [Related]
10. A comparison of 4-amino-4-deoxy-N10-methylpteroic acid and methotrexate transport by mouse leukemia cells. Kessel D. Mol Pharmacol; 1969 Jan 23; 5(1):21-5. PubMed ID: 5392912 [No Abstract] [Full Text] [Related]
11. Different effects of vincristine on methotrexate uptake by L1210 cells and mouse intestinal epithelia in vitro and in vivo. Chello PL, Sirotnak FM, Dorick DM. Cancer Res; 1979 Jun 23; 39(6 Pt 1):2106-12. PubMed ID: 445407 [No Abstract] [Full Text] [Related]
12. Relative frequency and kinetic properties of transport-defective phenotypes among methotrexate-resistant L1210 clonal cell lines derived in vivo. Sirotnak FM, Moccio DM, Kelleher LE, Goutas LJ. Cancer Res; 1981 Nov 23; 41(11 Pt 1):4447-52. PubMed ID: 7306968 [Abstract] [Full Text] [Related]
13. Activity of free and carrier-bound methotrexate against transport-deficient and high dihydrofolate dehydrogenase-containing methotrexate-resistant L1210 cells. Chu BC, Fan CC, Howell SB. J Natl Cancer Inst; 1981 Jan 23; 66(1):121-4. PubMed ID: 6935452 [Abstract] [Full Text] [Related]
14. The mechanism of transport of the multitargeted antifolate (MTA) and its cross-resistance pattern in cells with markedly impaired transport of methotrexate. Zhao R, Babani S, Gao F, Liu L, Goldman ID. Clin Cancer Res; 2000 Sep 23; 6(9):3687-95. PubMed ID: 10999762 [Abstract] [Full Text] [Related]
15. Modulation of methotrexate resistance by genistein in murine leukemia L1210 cells. Xuan Y, Hacker MP, Tritton TR, Bhushan A. Oncol Rep; 1998 Sep 23; 5(2):419-21. PubMed ID: 9468571 [Abstract] [Full Text] [Related]
16. Cyclic adenosine 3':5'-monophosphate and methotrexate transport in L1210 cells. Henderson GB, Zevely EM, Huennekens FM. Cancer Res; 1978 Mar 23; 38(3):859-61. PubMed ID: 203390 [Abstract] [Full Text] [Related]
17. Stereochemical characteristics of the folate-antifolate transport mechanism in L1210 Leukemia cells. Sirotnak FM, Donsbach RC. Cancer Res; 1974 Feb 23; 34(2):371-7. PubMed ID: 4855750 [No Abstract] [Full Text] [Related]
18. Effect of modification of plasma membrane fatty acid composition on fluidity and methotrexate transport in L1210 murine leukemia cells. Burns CP, Luttenegger DG, Dudley DT, Buettner GR, Spector AA. Cancer Res; 1979 May 23; 39(5):1726-32. PubMed ID: 218733 [No Abstract] [Full Text] [Related]
19. Increased accumulation of methotrexate by murine tumor cells in vitro in the presence of probenecid which is mediated by a preferential inhibition of efflux. Sirotnak FM, Moccio DM, Young CW. Cancer Res; 1981 Mar 23; 41(3):966-70. PubMed ID: 7459883 [Abstract] [Full Text] [Related]
20. Antifolate transport in L1210 leukemia cells. Kinetic evidence for the non-identity of carriers for influx and efflux. Dembo M, Sirotnak FM. Biochim Biophys Acta; 1976 Oct 19; 448(3):505-16. PubMed ID: 974145 [Abstract] [Full Text] [Related] Page: [Next] [New Search]